For U.S. Healthcare Professionals Only

Sanofi Genzyme Rare Diseases

The Sanofi Genzyme Rare Diseases Medical Affairs team helps Healthcare Professionals (HCPs) make evidence-based decisions that optimize health outcomes for patients through the generation, dissemination, and interpretation of accurate clinical and scientific information about Pompe disease, Gaucher disease, Fabry disease, and MPS I. This website facilitates educational opportunities for HCPs through (1) web-based learning, and (2) informing of Scientific Education Programs conducted in collaboration with the Rare Diseases Medical Science Liaison (MSL) team.

The Rare Diseases MSL team supports Sanofi Genzyme’s pipeline and commercial products by delivering scientific information, education, and research support to HCPs, researchers, and payers with the ultimate goal of improved patient care.

 

 

 

 

Last Updated: Feb 27, 2019

© 2002-2018 sanofi-aventis U.S. LLC. All rights reserved. Legal Disclaimer Information and Privacy Policy
Questions or Comments? Click here to contact us. Site Map This site is intended for use by U.S. residents only. SGUSMA.GZ.18.10.0577a Last Update: December 2018